Showing results (41-50 of 99) with videos related to
Sort By:
Pageof 10
AIMS Public Health|October 23, 2025
A data-driven mathematical model for evaluating the societal and economic burden of delayed access to innovative medicinesFoteini Theiakou, Catherine Kastanioti, Dimitris Rekkas, et al.Healthcare (Basel, Switzerland)|August 14, 2025
Barriers in Access to Healthcare Services in Greece Post-COVID-19: Persisting Challenges for Health PolicyKyriakos Souliotis, Christina Golna, Agni Baka, et al.Frontiers in Oncology|June 11, 2025
Strategies to accelerate cervical cancer elimination in Greece: a modeling studyCody Palmer, Anastasios Skroumpelos, Ugne Sabale, et al.Aging & Mental Health|October 19, 2016
Investigating burden of informal caregivers in England, Finland and Greece: an analysis with the short form of the Burden Scale for Family Caregivers (BSFC-s)Uwe Konerding, Tom Bowen, Paul Forte, et al.World Hospitals and Health Services : the Official Journal of the International Hospital Federation|August 13, 2009
The Greek healthcare systemVassiliki Siantou, Kostas Athanasakis, John KyriopoulosValue in Health Regional Issues|February 26, 2021
Can We Incorporate Societal Values in Resource Allocation Decisions Among Disease Categories? An Empirical ApproachKostas Athanasakis, Ilias Kyriopoulos, John KyriopoulosISRN Rheumatology|July 3, 2013
Investigating the value of abatacept in the treatment of rheumatoid arthritis: a systematic review of cost-effectiveness studiesKostas Athanasakis, Ioannis Petrakis, John KyriopoulosJournal of Epidemiology and Community Health|July 22, 2018
Are happy people healthier? An instrumental variable approach using data from GreeceIlias Kyriopoulos, Kostas Athanasakis, John KyriopoulosThe European Journal of General Practice|September 14, 2007
Determinants of healthcare utilization in Greece: implications for decision-makingMary Geitona, Dimitrios Zavras, John KyriopoulosHealth Economics Review|April 18, 2026
Consideration of the limitations of cost-effectiveness analysis for severe-rare disease drugs and potential solutions: a structured literature reviewJia Pan, Anastasios Skroumpelos, Anouska Jha, et al.Pageof 10